Clinical Trial Results TV
November 15, 2016: Dr. C. Michael Gibson Presents: AEGIS-I: The Safety and Tolerability of CSL112, A Reconstituted, Infusible, Human ApoA-I
Dr. C. Michael Gibson Presents: AEGIS-I: The Safety and Tolerability of CSL112, A
Reconstituted, Infusible, Human ApoA-I, After Acute Myocardial Infarction - The ApoA-I
Event Reduction In Ischemic Syndromes I (AEGIS-I) Trial

TBD

[ Download video ]


Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
02-21-2017 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted